Cancer Letters
Volume 228, Issue 1 , Pages 59-63 , 18 October 2005

Phox2B mutations and the Delta–Notch pathway in neuroblastoma

  • Vera van Limpt

      Affiliations

    • Department of Human Genetics, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands
  • ,
  • Alvin Chan

      Affiliations

    • Department of Human Genetics, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands
  • ,
  • Alexander Schramm

      Affiliations

    • Department of Oncology/Hematology and Endocrinology, University Children's Hospital Essen, Hufelandstrs. 55, 45122 Essen, Germany
  • ,
  • Angelika Eggert

      Affiliations

    • Department of Oncology/Hematology and Endocrinology, University Children's Hospital Essen, Hufelandstrs. 55, 45122 Essen, Germany
  • ,
  • Rogier Versteeg

      Affiliations

    • Department of Human Genetics, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 10 463 6691/2073; fax: +31 10 463 6801.

Received 3 January 2005 ,Accepted 5 February 2005.

References 

  1. Pattyn A, Morin X, Cremer H, Goridis C, Brunet JF. The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature. 1999;399:366–370
  2. Yang C, Kim HS, Seo H, Kim CH, Brunet JF, Kim KS. Paired-like homeodomain proteins, Phox2a and Phox2b, are responsible for noradrenergic cell-specific transcription of the dopamine beta-hydroxylase gene. J. Neurochem. 1998;71:1813–1826
  3. Xu H, Firulli AB, Zhang X, Howard MJ. HAND2 synergistically enhances transcription of dopamine-beta-hydroxylase in the presence of Phox2a. Dev. Biol. 2003;262:183–193
  4. Rychlik JL, Gerbasi V, Lewis EJ. The interaction between dHAND and Arix at the dopamine beta-hydroxylase promoter region is independent of direct dHAND binding to DNA. J. Biol. Chem. 2003;278:49652–49660
  5. Pattyn A, Goridis C, Brunet JF. Specification of the central noradrenergic phenotype by the homeobox gene Phox2b. Mol. Cell. Neurosci. 2000;15:235–243
  6. Brunet JF, Pattyn A. Phox2 genes—from patterning to connectivity. Curr. Opin. Genet. Dev. 2002;12:435–440
  7. Latchaw RE, L'Heureux PR, Young G, Priest JR. Neuroblastoma presenting as central nervous system disease. AJNR. Am. J. Neuroradiol. 1982;3:623–630
  8. Amiel J, Laudier B, Attie-Bitach T, Trang H, De Pontual L, Gener B, et al. Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat. Genet. 2003;33:459–461
  9. Weese-Mayer DE, Berry-Kravis EM, Zhou L, Maher BS, Silvestri JM, Curran ME, et al. Idiopathic congenital central hypoventilation syndrome: analysis of genes pertinent to early autonomic nervous system embryologic development and identification of mutations in PHOX2b. Am. J. Med. Genet. 2003;123A:267–278
  10. Sasaki A, Kanai M, Kijima K, Akaba K, Hashimoto M, Hasegawa H, et al. Molecular analysis of congenital central hypoventilation syndrome. Hum. Genet. 2003;114:22–26
  11. van Limpt A, Schramm A, Lakeman A, Sluis PV, Chan A, van Noesel M, et al. The Phox2B homeobox gene is mutated in sporadic neuroblastoma. Oncogene. 2004;23:9280–9288
  12. Trochet D, Bourdeaut F, Janoueix-Lerosey I, Deville A, De Pontual L, Schleiermacher G, et al. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma. Am. J. Hum. Genet. 2004;74:761–764
  13. Mosse YP, Laudenslager M, Khazi D, Carlisle AJ, Winter CL, Rappaport E, et al. Germline PHOX2B mutation in hereditary neuroblastoma. Am. J. Hum. Genet. 2004;75:727–730
  14. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N. Engl. J. Med. 1993;328:847–854
  15. Iso T, Kedes L, Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J. Cell Physiol. 2003;194:237–255
  16. Seugnet L, Simpson P, Haenlin M. Transcriptional regulation of Notch and Delta: requirement for neuroblast segregation in Drosophila. Development. 1997;124:2015–2025
  17. Haenlin M, Kunisch M, Kramatschek B, Campos-Ortega JA. Genomic regions regulating early embryonic expression of the Drosophila neurogenic gene Delta. Mech. Dev. 1994;47:99–110
  18. Kunisch M, Haenlin M, Campos-Ortega JA. Lateral inhibition mediated by the Drosophila neurogenic gene delta is enhanced by proneural proteins. Proc. Natl Acad. Sci. USA. 1994;91:10139–10143
  19. Heitzler P, Bourouis M, Ruel L, Carteret C, Simpson P. Genes of the Enhancer of split and achaete–scute complexes are required for a regulatory loop between notch and delta during lateral signalling in Drosophila. Development. 1996;122:161–171
  20. Muskavitch MA. Delta–Notch signaling and Drosophila cell fate choice. Dev. Biol. 1994;166:415–430
  21. Beatus P, Lendahl U. Notch and neurogenesis. J. Neurosci. Res. 1998;54:125–136
  22. Morrison SJ, Perez SE, Qiao Z, Verdi JM, Hicks C, Weinmaster G, et al. Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells. Cell. 2000;101:499–510
  23. van Limpt VA, Chan AJ, Van Sluis PG, Caron HN, Van Noesel CJ, Versteeg R. High delta-like 1 expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell type. Int. J. Cancer. 2003;105:61–69
  24. Hirsch MR, Tiveron MC, Guillemot F, Brunet JF, Goridis C. Control of noradrenergic differentiation and Phox2a expression by MASH1 in the central and peripheral nervous system. Development. 1998;125:599–608
  25. Lo L, Tiveron MC, Anderson DJ. MASH1 activates expression of the paired homeodomain transcription factor Phox2a, and couples pan-neuronal and subtype-specific components of autonomic neuronal identity. Development. 1998;125:609–620
  26. Firulli AB. An HANDful of questions: the molecular biology of the heart and neural crest derivatives (HAND)-subclass of basic helix-loop-helix transcription factors. Gene. 2003;312:27–40

PII: S0304-3835(05)00361-7

doi: 10.1016/j.canlet.2005.02.050

Cancer Letters
Volume 228, Issue 1 , Pages 59-63 , 18 October 2005